Absci and AMD Announce Collaboration and Strategic Investment …
2 days ago · “Absci’s groundbreaking work in AI drug discovery is a perfect fit for AMD high-performance computing solutions and software, designed for the most demanding AI workloads.” About Absci Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
Absci and AMD Announce Collaboration and Strategic Investment …
1 day ago · VANCOUVER, Wash., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
1 day ago · Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery. AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company ...
Absci Shares Rise 27% on Report of $20 Mln Investment
Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. ... Dow Jones Newswires is a market-moving financial and business news source, used ...
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Absci Announces Strategic Collaboration With AMD To Advance …
1 day ago · (RTTNews) - Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to ...
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI …
Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare sector ...
Absci and Invetx Partner to Bring Generative AI Drug Creation …
3 days ago · VANCOUVER, Wash. and BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx, a pioneer in protein-based ...
AMD invests $20 million in AI drug research at Vancouver-based Absci
1 day ago · The investment sent Absci shares up nearly 5% Wednesday, to $3.22. The companies didn’t disclose the price AMD is paying for shares in the Vancouver company. Absci employs about 160, including ...
Absci Corporation Announces Strategic Collaboration with AMD
1 day ago · Absci partners with AMD, investing $20 million to enhance AI-driven drug discovery and antibody design capabilities. Quiver AI Summary. Absci Corporation has announced a strategic partnership with ...